Prokidney (PROK) Depreciation and Depletion (2021 - 2026)
Prokidney's (PROK) quarterly Depreciation and Depletion came in at $1.4 million in Q1 2026, up 3.68% year-on-year from $1.4 million in Q1 2025, and down 0.97% on a QoQ basis from $1.4 million in Q4 2025.
Prokidney (PROK) Depreciation and Depletion (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Depreciation and Depletion data on file, last reported at $1.4 million in Q1 2026.
- On a quarterly basis, Depreciation and Depletion rose 3.68% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $5.8 million, a 18.11% increase from a year earlier, with the FY2025 full-year figure at $5.7 million, up 31.93% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $1.4 million, down from $1.4 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for PROK reached as high as $1.5 million in Q2 2025 and fell as low as $593000.0 in Q1 2022.
- Historically, Depreciation and Depletion has averaged $994000.0 across 5 years, with a median of $872000.0 in 2023.
- Across the five-year window, Depreciation and Depletion soared 66.35% in 2025 and gained 3.68% in 2026, its largest moves.
- Year by year, Depreciation and Depletion stood at $623000.0 in 2022, then soared by 39.97% to $872000.0 in 2023, then jumped by 53.78% to $1.3 million in 2024, then increased by 8.05% to $1.4 million in 2025, then dropped by 0.97% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $1.4 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | 1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.44 Mn |
| Mar 31, 2026 | 1.44 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 964,000.00 |
| Jun 30, 2024 | 964,000.00 |
| Mar 31, 2024 | 832,000.00 |
| Mar 31, 2024 | 832,000.00 |
| Dec 31, 2023 | 872,000.00 |
| Dec 31, 2023 | 872,000.00 |